Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Finasteride causes temporary cell death in BPH tissues.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Aging reduces stem cell activation, leading to hair loss in mice lacking a specific enzyme.

A 60-year-old man with Cronkhite-Canada syndrome improved with treatment, but the condition has a high mortality rate and a risk of colorectal cancer.

Stopping alpha-blocker medication after 6-9 months is safe and effective for most patients with bladder outlet obstruction.

Lycopene protects against testicular damage caused by finasteride.

Tamsulosin and solifenacin together effectively reduce symptoms in BPH patients.

Chikungunya can cause hyperpigmentation in children and should be considered in diagnosis.

Post-finasteride syndrome is rare but serious and should be taken seriously.

Argentine-cross polo ponies commonly develop sarcoid tumors with distinct types and histopathological features.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

HoxC genes are crucial for normal hair and nail development.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

Finasteride causes harmful organ changes in female mice.

Diagnosing simple-virilizing congenital adrenal hyperplasia can be difficult and requires thorough testing and expert advice.

Lambs' skin showed similar but more severe responses to a second orf virus infection, involving immune cells and new skin formation.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Early hair loss may indicate prostate issues.

Finasteride affects prostate weights and pituitary activity differently with age.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

PCOS is a major cause of infertility in women of childbearing age.

Topical glucocorticoids thin the skin and change collagen structure.

Different oil products cause varying levels of skin irritation in mice, which could potentially lead to tumors.